Sign in:
Email
 Password  save:
  
 Company Reports 
 
   
My Recent Searches
  Help
 
   
 
 
Get Insiders for : 
Cyteir Therapeutics, Inc. (CYT)  
$3.02 0.00 (0.00%) as of 4:30 Fri 3/15


Download
   
Exchange: N/A
Security Type: Common
Shares Out: 35,370,000
Market Cap: 106.82(M)
Last Volume: 0 Avg Vol: 0
52 Week Range: $1.74 - $3.15
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:

   

Rankings:

     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   Cyteir Therapeutics is a clinical-stage biotechnology company focused on developing and commercializing the oncology medicines that inhibit deoxyribonucleic acid damage repair and cause cancer cell death in specific subsets of cancer patients through a therapeutic strategy known as synthetic lethality. Co.'s primary program, CYT-0851, was identified through a phenotypic screening strategy that exploited a synthetic lethality between cytidine deaminases (CD) overexpression and homologous recombination inhibition. The screen was designed to select for compounds that induced synthetic lethality in CD-overexpressing cancer cells while sparing normal cells.


 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 284,366 284,366 284,366 366,717
Total Buy Value $845,707 $845,707 $845,707 $989,543
Total People Bought 1 1 1 3
Total Buy Transactions 2 2 2 7
Total Shares Sold 0 0 401,548 1,301,548
Total Sell Value $0 $0 $1,026,787 $3,726,787
Total People Sold 0 0 1 1
Total Sell Transactions 0 0 14 15
End Date 2024-02-04 2023-11-03 2023-05-05 2022-05-05

   
Records found: 59
  Page 2 of 3  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

 
3m +/-  
Form
   Novo A/s 10% Owner   –       –       •   2023-06-22 4 S $1.94 $9,783 D/D (5,041) 3,907,411 -53%     
   Novo A/s 10% Owner   –       –       •   2023-06-21 4 S $1.99 $9,641 D/D (4,834) 3,912,452 -52%     
   Novo A/s 10% Owner   –       –       •   2023-06-14 4 S $2.11 $6,050 D/D (2,872) 3,934,015 -42%     
   Novo A/s 10% Owner   –       –       •   2023-06-13 4 S $2.10 $5,515 D/D (2,626) 3,936,887 -43%     
   Novo A/s 10% Owner   –       –       •   2023-06-12 4 S $2.06 $1,858 D/D (900) 3,939,513 -42%     
   Renschler Markus Md President and CEO   •       •      –    2023-01-13 4 A $1.49 $7,450 D/D 5,000 983,736     -
   Gaiero David G Chief Financial Officer   •       –      –    2023-01-13 4 A $1.49 $7,450 D/D 5,000 9,100     -
   Zakrzewski Joseph S Director   –       •      –    2022-12-07 4 B $1.30 $27,563 D/D 21,202 154,618 2.39 54%     
   Novo A/s 10% Owner   –       –       •   2022-07-20 4 S $3.00 $2,700,000 D/D (900,000) 3,940,413 64%     
   Zakrzewski Joseph S Director   –       •      –    2022-05-12 4 B $1.61 $1,196 D/D 743 133,416 2.31 19%     
   Zakrzewski Joseph S Director   –       •      –    2022-05-11 4 B $1.70 $1,700 D/D 1,000 132,673 2.31 21%     
   Thero John F Director   –       •      –    2022-05-10 4 B $2.00 $20,000 D/D 10,000 10,000 2.39 6%     
   Zakrzewski Joseph S Director   –       •      –    2022-05-10 4 B $1.89 $93,377 D/D 49,406 131,673 2.39 6%     
   Zakrzewski Joseph S Director   –       •      –    2021-12-28 4 B $9.85 $5,920 D/D 601 82,267 2.39 -81%     
   Zakrzewski Joseph S Director   –       •      –    2021-12-27 4 B $9.97 $3,002 D/D 299 81,666 2.31 -80%     
   Zakrzewski Joseph S Director   –       •      –    2021-12-23 4 B $9.87 $1,974 D/D 200 81,367 2.31 -77%     
   Gaiero David G Chief Financial Officer   •       –      –    2021-12-20 4 OE $1.68 $6,888 D/D 4,100 4,100     -
   Zakrzewski Joseph S Director   –       •      –    2021-12-17 4 B $9.88 $1,976 D/D 200 81,167 2.31 -77%     
   Zakrzewski Joseph S Director   –       •      –    2021-12-15 4 B $10.47 $39,844 D/D 3,700 80,967 2.39 -76%     
   Naesens Janwillem Director   –       •      –    2021-06-22 4 B $18.00 $4,999,986 I/I 277,777 3,536,803 2.1 -2%     
   Naesens Janwillem Director   –       •      –    2021-06-22 4 A $0.00 $0 I/I 3,259,026 3,259,026     -
   George Jean Director   –       •      –    2021-06-22 4 A $0.00 $0 I/I 2,444,268 2,444,268     -
   Zakrzewski Joseph S Director   –       •      –    2021-06-22 4 A $0.00 $0 I/I 58,671 58,671     -
   Naesens Janwillem 10% Owner   –       –       •   2021-06-22 4 B $18.00 $4,999,986 D/D 277,777 3,536,803 2.45 -2%     
   Naesens Janwillem 10% Owner   –       –       •   2021-06-22 4 A $0.00 $0 D/D 3,259,026 3,259,026     -

  59 Records found
  1  2  3   
  Page 2 of 3
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed